Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ISRCTN11479933) titled 'Testing a sustainable packaging system to reduce pharmaceutical waste and support a net-zero NHS' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Device feasibility
Primary Sponsor: Clatterbridge Cancer Centre NHS Foundation Trust
Condition:
Patients receiving oral anti-cancer medicines
Other
Intervention:
Consenting participants will receive their prescribed OACM in its standard manufacturer packaging, but contained within the PharmaBag over-packing system. They will receive written in...